AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
June 03, 2024 08:00 ET
|
Avricore Health Inc.
Q1 2024 Results
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
May 21, 2024 08:45 ET
|
Dalrada Financial Corp.
Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy.
United States Ophthalmic Market Size to Surpass Around US$ 36.50 Billion 2031, Recording a CAGR of 8.6%, Report by CoherentMI
May 20, 2024 19:10 ET
|
CMI
Burlingame, May 20, 2024 (GLOBE NEWSWIRE) -- CoherentMI published a report, titled, United States Ophthalmic Market was valued at US$ 15.90 Billion in the year 2023, and is anticipated to reach a...
[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 20, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, May 20, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Colorectal Cancer Market Size, Trends and Insights By Type of Treatment (Surgery,...
Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
May 16, 2024 08:45 ET
|
Dalrada Financial Corp.
Company’s pharmaceutical subsidiary continues to drive impressive growth accounting for nearly 80% of Q3 2024 revenue
MRSA Drugs Global Strategic Research Report 2024: Market to Reach $1.6 Billion by 2030 - Glycopeptides & Lipoglycopeptides to Account for $660 Million
May 13, 2024 09:55 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "MRSA Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global MRSA Drugs Market to Reach $1.6...
Compounding Pharmacy Global Strategic Business Report 2024: Market to Reach $17.7 Billion by 2030 from $13 Billion in 2023
May 13, 2024 09:49 ET
|
Research and Markets
Dublin, May 13, 2024 (GLOBE NEWSWIRE) -- The "Compounding Pharmacy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Compounding Pharmacy Market...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – GDRX
May 12, 2024 14:02 ET
|
The Rosen Law Firm PA
NEW YORK, May 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GoodRx Holdings, Inc. (NASDAQ: GDRX) between September...
Visory Health's New Prescription Habits Report Reveals Medication Affordability Challenges Among Millennials, the Sandwich Generation and Beyond
May 07, 2024 09:00 ET
|
Visory Health
ESTERO, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- Visory Health, a women-led, patient-first health tech prescription platform that is transforming the way women, families, and caregivers access...
[Latest] Global Cancer Cachexia Market Size/Share Worth USD 5.1 Billion by 2033 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 03, 2024 04:30 ET
|
Custom Market Insights
Austin, TX, USA, May 03, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Cachexia Market Size, Trends and Insights By Therapeutics (Progestogen,...